HomeOpen Access NewsCancer Research

Cancer Research

£5.5 million pledged to transform bowel cancer care

Research institutes have committed £5.5 million in funding for a world-leading research team tasked with making personalised medicines for bowel cancer patients.

Breast cancer survival rate sees a 66% improvement over 20 years

Women with early stage breast cancer today are 66% less likely to die within five years of diagnosis than they were in the 1990s, research on the breast cancer survival rate finds.

Following cancer prevention recommendations reduces risk of the disease

Following global cancer prevention recommendations reduces the risk of developing the disease according to latest study.

Universal receptor system allows customizable immunotherapies for cancer

A universal receptor system that enables T cells to recognize any cell surface target has been created by University of Pittsburgh researchers, which could revolutionise customizable immunotherapies for treating cancer and other diseases.

How AI can optimise early cancer treatment

Early cancer treatment is vital to sustaining high cancer survival rates, but could AI improve clinician capabilities and predict worse cases?

Improving cancer therapy using sonoenhancement with acoustic cluster therapy

Sonoenhancement with Acoustic Cluster Therapy (ACT®) improves drug delivery to solid tumors, and by that reduces the necessary doses and side effects.

Can neurodevelopmental disorders affect testicular cancer occurrence?

Research finds that men who have a neurodevelopmental disorder, such as autism and ADHD, also have a slightly increased risk of testicular cancer.

Can AI be used to predict and prevent breast cancer?

Lester Litchfield, Head of Data Science at Volpara Health, discusses the future of artificial intelligence in breast health.

Cancer survival rates rise by 9% nationally in the NHS

NHS England has published a one-year cancer survival index, showing how cancer survival rates have improved across the country by almost 10%.

Advancements in how we identify and treat hypoxic cancers

Cancers that are starved of oxygen, otherwise known as hypoxic cancers, are generally difficult to identify – but medical imaging has taken a new step with the MR-Linac scanner.

Intelligent triage: a vital step toward resolving the problem of capacity in NHS cancer services and cancer referrals

AI offers an opportunity to reimagine our approach to cancer diagnostics, leveraging data to build a more robust and efficient system for cancer referrals.

Machine learning and prognostics in cancer programmes

Tim Simpson, General Manager of Hologic UK & Ireland, discusses how AI, machine learning and prognostics could revolutionise cancer detection and treatment in breast and cervical cancer programmes.

Can technology help detect brain tumours through urine analysis?

Researchers have revealed a new and non-invasive way to detect brain tumours through a device that identifies a key membrane protein in a patient's urine.

Addressing the chasm in UK cancer care

Stefan Doroszkowski, Managing Director at Amethyst Radiotherapy Group UK, shares his stance on responding to the cancer care crisis, addressing the chasm in UK cancer care.

Cancer vaccine trials encourage personalised immunotherapies

A new partnership will help accelerate clinical trials across the UK for a cancer vaccine with the potential for personalised immunotherapies.

How integrative oncology is transforming cancer care

Santosh Rao, Channing J. Paller, Ana Maria Lopez, Eugene Ahn, Jodi MacLeod, Ting Bao, and Linda E. Carlson, from the Society for Integrative Oncology, detail how integrative oncology is transforming cancer care.

Exploring the human epidermal growth factor receptor 2 (HER2)

Gail Dianne Lewis, the Senior Principal Scientist at Discovery Oncology Genentech, Inc. analyses the human epidermal growth factor receptor 2.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders